ROS1 is a receptor tyrosine kinase and gene rearrangements leading to ROS1 overexpression are therapeutic biomarkers of response to ROS1 kinase inhibitors in non-small-cell lung cancer and other cancer types (Supplementary Fig. 2c)17. The gene discussed is ROS1; the disease is cancer.